From AI validation to microstructure imaging, AAPS PharmSci 360 speakers pushed toward faster drug development backed by stronger evidence. Here are PharmTech's biggest takeaways.
|Articles|May 2, 2017
Catalent Pharma Solutions
Advertisement
At CPhI North America, Catalent will showcase its OptiForm® Solution Suite and OptiForm Solution Suite Bio, which combine predictive and high throughput screening technologies to identify the most stable and efficient drug form for both small and biological molecules. Using known industry models, multiple formulations are evaluated in parallel and proven delivery technologies employed to offer optimal oral delivery.
14 Schoolhouse Road, Somerset, NJ 08873
tel. +1 888 SOLUTION
CPhI North America Booth #3101
Advertisement
Related to this article
The FDA approves asundexian, the first factor XIa inhibitor, cutting stroke risk 26% and setting a regulatory benchmark for factor XI drug developers.
Panelists on the PharmTech AI Pulse Check weigh a December AI playbook, EMA/MHRA moves, PCCP accountability gaps, and MCP-ready regulatory guidance.
France’s 2030 Health Initiative is driving growth in biotechnology, health innovation, biomanufacturing, and digital health.
CPHI Award winner, Pauline van der Wijst-Janssen, PhD, product development manager and global technical lead at DFE Pharma, explains excipient variability and excipients’ role in continuous manufacturing.
Pauline van der Wijst-Janssen, PhD, of DFE Pharma, won the CPHI Pharma Award for Future Leader. In this interview with PharmTech, she provides advice for scientists looking to advance to leadership roles.
Coverage from AAPS PharmSci 360 and CPHI Milan featured discussion about impurities, devices, and supply resilience. This week also included topics such as AI accountability, oral peptides, and new licensing deals.
No operator touches a CAR-T batch before demonstrating proficiency. Generative AI users should meet the same standard, and a higher one, because an AI error does not stay inside one batch.
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Why Drug Shortages Average 5+ Years: PharmTech Explained
2
CDMOs, OEMs, and Used Equipment Resellers are Joining Forces to Onshore Pharmaceutical Manufacturing
3
What the First Factor XIa Approval Means for Developers
4
$1.15B AI-Guided Macrocycle Discovery Lands at argenx
5